Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Maxim Group Downgrades Bionano Genomics to Hold

Author: Benzinga Newsdesk | November 13, 2023 08:55am
Maxim Group analyst Jason McCarthy downgrades Bionano Genomics (NASDAQ:BNGO) from Buy to Hold.

Posted In: BNGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist